A special collection of new articles published in The Journal of Infectious Diseases highlights the great benefits to human health achieved by the development and use of vaccines.
A special collection of new articles published in The Journal of Infectious Diseases highlights the great benefits to human health achieved by the development and use of vaccines.
IDSA has stated its opposition to the National Quality Forum’s re-endorsement of the Severe Sepsis and Septic Shock: Early Management Bundle (SEP-1) quality measure, as the Society has major concerns with the SEP-1 measure as it is currently specified.
Researchers at Vanderbilt University Medical Center found that despite improvements in mortality rates among people with HIV over 20 years, women had a higher risk of mortality than men, and Black women had the highest years of potential life lost, according to a study presented at IDWeek.
The Infectious Diseases Society of America is honoring 12 exemplary leaders in the field at IDWeek 2021. IDSA is pleased to recognize the following members for excellence in the field of infectious diseases:
New research shows that in 2020-2021, while the circulation of influenza, RSV, and other respiratory viruses declined sharply, rhinovirus/enterovirus – which causes the common cold – persisted and continued to circulate among children, according to a study presented at IDWeek.
A new program to ensure antibiotics are used properly, funded by the Agency for Healthcare Research and Quality (AHRQ), was associated with declines in antibiotic prescribing in ambulatory clinics even in the face of COVID-19 related disruptions, according to results presented at IDWeek.
IDSA Foundation, in collaboration with JLABS, recently awarded more than $17,000 in funding through the 2021 IDea Incubator competition to three finalists for their promising innovations aimed at advancing the field of infectious diseases.
Five new members join Board of Directors to continue the fight against COVID-19 and promote the value of ID specialists. IDSA is pleased to announce Daniel P. McQuillen, MD, FIDSA, as the society’s new president beginning Oct. 4.
IDSA and its HIVMA support the Biden Administration’s call for new global commitments to control the COVID-19 pandemic and applaud the Administration’s initial steps of donating vaccine doses and making financial contributions to COVAX, the COVID-19 Vaccines Global Access initiative.
IDSA is encouraged by today’s announcement from the Biden Administration on the allocation of more than $2 billion of American Rescue Plan funds to support infection prevention and efforts to combat antimicrobial resistance.
IDSA has expressed support for several proposed revisions to The Joint Commission’s antibiotic stewardship requirements for hospitals, while also providing additional recommendations to ensure the changes align with the Society’s strategic priorities.
IDSA supports President Biden’s multi-pronged approach to boost vaccination rates and strengthen our COVID-19 response. With COVID-19 cases on the rise and health systems stretched to capacity, it is imperative to public health and safety that eligible people get vaccinated.